Commentary Outrage of the Month: Editors of Prestigious Journal Sacrifice Standards to Defend an Unethical Clinical Trial November 12, 2015
Letters, Testimony & Filings Coalition Letter to U.S. Senate Finance Committee Calls for Release of Findings of Investigation of Opioid Makers September 16, 2015
Letters, Testimony & Filings Testimony Before the FDA’s Analgesic and Anesthetic Drug Products Advisory Committee Meeting on Moxduo April 22, 2014
Letters, Testimony & Filings Letter to Senator Joe Manchin Urging Him to Investigate FDA’s Decision to Approve Dangerous High-Dose Opioid March 14, 2014
Commentary Outrage of the Month: Dangerous New Opioid Pain Drug Scheduled to Hit U.S. Market in March March 1, 2014
Letters, Testimony & Filings Letter to the FDA Asking the Agency to Keep Dangerous High-Dose Opioid Drug Off the Market February 26, 2014
Letters, Testimony & Filings Testimony to Drug Safety and Risk Management Advisory Committee on Overprescription of Hydrocodone January 25, 2013